DCOY - Latest News
Decoy Therapeutics Inc. (DCOY), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.5M. Beta to the broader market is 0.58.
The article list below shows the most recent DCOY headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent DCOY Headlines
Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform
prnewswire.com - Aug 3, 2026
Portfolio now spans seven patent families and 19 pending applications across seven jurisdictions, protecting antiviral peptide conjugates, the methods
Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats
prnewswire.com - Jul 27, 2026
Lead D-MAV demonstrates cross-viral family fusion inhibition, validating theplatform; opens a new program in filovirus pandemic preparedness CAMBRIDGE
Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors
prnewswire.com - Jul 15, 2026
CAMBRIDGE, Mass. , July 15, 2026 /PRNewswire/ -- Decoy Therapeutics Inc.
Decoy Stock Rises After Announcing Up to $21 Million Private Placement Financing
benzinga.com - Jun 29, 2026
Decoy Therapeutics Inc. (NASDAQ:DCOY) shares are trading higher.
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
gurufocus.com - Jun 26, 2026
Decoy Therapeutics, Inc.
How News Affects DCOY Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track DCOY's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked DCOY news questions
- What is the latest DCOY news headline?
- The most recent DCOY headline (Aug 3, 2026) is "Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the DCOY news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What DCOY news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual DCOY options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.